NORTHERN TRUST CORP - BENITEC BIOPHARMA INC ownership

BENITEC BIOPHARMA INC's ticker is BNTC and the CUSIP is 08205P100. A total of 18 filers reported holding BENITEC BIOPHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of BENITEC BIOPHARMA INC
ValueSharesWeighting
Q2 2023$2,817
+13.6%
11,8130.0%0.00%
Q1 2023$2,480
+23.5%
11,8130.0%0.00%
Q4 2022$2,008
-49.8%
11,8130.0%0.00%
Q3 2022$4,000
-71.4%
11,8130.0%0.00%
Q2 2022$14,000
-50.0%
11,8130.0%0.00%
Q1 2022$28,000
-9.7%
11,8130.0%0.00%
Q4 2021$31,000
-26.2%
11,8130.0%0.00%
Q3 2021$42,000
-16.0%
11,8130.0%0.00%
Q2 2021$50,00011,8130.00%
Other shareholders
BENITEC BIOPHARMA INC shareholders Q4 2021
NameSharesValueWeighting ↓
SUVRETTA CAPITAL MANAGEMENT, LLC 769,000$1,796,0000.06%
Atom Investors LP 37,335$87,0000.04%
SILVERARC CAPITAL MANAGEMENT, LLC 492,880$57,0000.02%
WealthTrust Axiom LLC 12,950$30,0000.01%
UBS Group AG 347$1,0000.00%
WELLS FARGO & COMPANY/MN 43$00.00%
NORTHERN TRUST CORP 11,813$28,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 2,000$5,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 59,566$139,0000.00%
View complete list of BENITEC BIOPHARMA INC shareholders